Greedy Insider
CRNX Insider Trades and Greediness Scores
Crinetics Pharmaceuticals, Inc. (CRNX) insider trades: since Dec 1, 2025, Greedy Insider recorded 0 open-market buys and 118 sales on Form 4 from 13 insiders. The strongest recent filing scored 91 (Strong).
Who bought and who sold
Across the last 118 scoreable Form 4 transactions in CRNX, 0 were open-market purchases and 118 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| Betz Stephen F. | Chief Scientific Officer | Sell | 74540.0 | 5644169.0 | 2026-09-01 | 88 | View |
| Betz Stephen F. | Chief Scientific Officer | Sell | 60000.0 | 3743400.0 | 2026-09-01 | 85 | View |
| Betz Stephen F. | Chief Scientific Officer | Sell | 85000.0 | 5925350.0 | 2026-09-01 | 88 | View |
| Okey Stephanie | Director | Sell | 9730.0 | 478034.9 | 2026-09-01 | 78 | View |
| Bedrosian Camille L | Director | Sell | 10350.0 | 545134.5 | 2026-09-01 | 76 | View |
| Bedrosian Camille L | Director | Sell | 9730.0 | 478034.9 | 2026-09-01 | 75 | View |
| Bedrosian Camille L | Director | Sell | 17500.0 | 1167425.0 | 2026-09-01 | 82 | View |
| Deardorf Caren | Director | Sell | 5925.0 | 503625.0 | 2026-09-01 | 76 | View |
| Deardorf Caren | Director | Sell | 35000.0 | 2299500.0 | 2026-09-01 | 87 | View |
| Deardorf Caren | Director | Sell | 4375.0 | 291856.25 | 2026-09-01 | 72 | View |
The strongest recent filing
Schilke Tobin (CFO) sold 71,471 shares of Crinetics Pharmaceuticals, Inc. on Sep 1, 2026, a filing that scored 91 (Strong). It scored Strong because a senior insider was trading and several insiders moved the same way within a week. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 11 insiders (Betz Stephen F., Okey Stephanie, Bedrosian Camille L, Deardorf Caren) traded CRNX the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with Crinetics Pharmaceuticals, Inc.'s own history
Open-market buys make up 0% of the 118 scoreable CRNX transactions on record between Dec 1, 2025 and Sep 1, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 118
- Open-market buys: 0
- Sales: 118
- Distinct insiders: 13
- Strongest recent Greediness Score: 91 (Strong)
Primary sources
Related
- Strongest filing
- CRNX in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.